Aquestive therapeutics provides business update and outlines key 2023 objectives

Warren, n.j., jan. 06, 2023 (globe newswire) -- aquestive therapeutics, inc. (nasdaq: aqst) (the “company” or “aquestive”), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care and provide transformative products to improve their lives, today provided an update on recent business developments and outlined key 2023 objectives. in addition, aquestive's chief executive officer, daniel barber, and chief financial officer, ernie toth, will host investor meetings from january 9 to 11, 2023 in san francisco, concurrent with the 41st annual j. p. morgan healthcare conference.
AQST Ratings Summary
AQST Quant Ranking